LEVETIRACETAM DEXCEL 1000

Country: Ísrael

Tungumál: enska

Heimild: Ministry of Health

Virkt innihaldsefni:

LEVETIRACETAM

Fáanlegur frá:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC númer:

N03AX14

Lyfjaform:

TABLETS

Samsetning:

LEVETIRACETAM 1000 MG

Stjórnsýsluleið:

PER OS

Gerð lyfseðils:

Required

Framleitt af:

DEXCEL LTD, ISRAEL

Meðferðarhópur:

LEVETIRACETAM

Lækningarsvæði:

LEVETIRACETAM

Ábendingar:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Leyfisdagur:

2018-03-31